| Literature DB >> 19540335 |
Fabiana Bettoni1, Fernando Camargo Filho, Daniela M Grosso, Pedro A F Galante, Raphael B Parmigiani, Murilo V Geraldo, Flávio Henrique-Silva, Sueli M Oba-Shinjo, Suely K N Marie, Fernando A Soares, Helena P Brentani, Andrew J G Simpson, Sandro J de Souza, Anamaria A Camargo.
Abstract
Cancer/testis Antigens (CTAs) are immunogenic proteins with a restricted expression pattern in normal tissues and aberrant expression in different types of tumors being considered promising candidates for immunotherapy. We used the alignment between EST sequences and the human genome sequence to identify novel CT genes. By examining the EST tissue composition of known CT clusters we defined parameters for the selection of 1184 EST clusters corresponding to putative CT genes. The expression pattern of 70 CT gene candidates was evaluated by RT-PCR in 21 normal tissues, 17 tumor cell lines and 160 primary tumors. We were able to identify 4 CT genes expressed in different types of tumors. The presence of antibodies against the protein encoded by 1 of these 4 CT genes (FAM46D) was exclusively detected in plasma samples from cancer patients. Due to its restricted expression pattern and immunogenicity FAM46D represents a novel target for cancer immunotherapy.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19540335 DOI： 10.1016/j.ygeno.2009.06.001
Source DB: PubMed Journal: Genomics ISSN： 0888-7543 Impact factor: 5.736